A therapeutic exploratory study to determine the efficacy and safety of calcineurin-inhibitor-free de-novo immunosuppression after liver transplantation: CILT

BACKGROUND: Immunosuppression with calcineurin inhibitors (CNI) increases the risk of renal dysfunction after orthotopic liver transplantation (OLT). Controlled trials have shown improvement of renal function in patients that received delayed and/or reduced-dose CNI after OLT. Delaying immunosuppres...

Descripción completa

Detalles Bibliográficos
Autores principales: Goralczyk, Armin D, Schnitzbauer, Andreas, Tsui, Tung Y, Ramadori, Giuliano, Lorf, Thomas, Obed, Aiman
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Study protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858131/
https://www.ncbi.nlm.nih.gov/pubmed/20380712
http://dx.doi.org/10.1186/1471-2482-10-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2858131/
https://www.ncbi.nlm.nih.gov/pubmed/20380712
http://dx.doi.org/10.1186/1471-2482-10-15

Ejemplares similares